# Linagliptin

## Trajenta 5mg

#### 一般可用

| 藥品代碼       | OTRAJ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:---------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Management of type 2 diabetes mellitus (noninsulin dependent， NIDDM) as an adjunct to diet and exercise as monotherapy or in combination with other antidiabetic agents.                                                                                                                                                                                                                                                                                                                                         |
| 用法用量       | 5 mg once daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 禁忌           | Hypersensitivity to linagliptin or any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 副作用         | >10%: Endocrine & metabolic: Hypoglycemia (combined with metformin/sulfonylurea [15%]， metformin [<1%]， pioglitazone [<1%]; monotherapy [<1%]) Central nervous system: Headache (6%) Endocrine & metabolic: Hyperuricemia (3%)， lipids increased (3%)， triglycerides increased (2%)， weight gain (2%) Neuromuscular & skeletal: Arthralgia (6%)， back pain (6%) Respiratory: Nasopharyngitis (6%)， cough (2%) <1% (Limited to important or life-threatening): Angioedema， hypersensitivity， pancreatitis |
| 孕期用藥建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                               |

